The Biocidal Products Regulation (Reg. (EU) n. 528/2012 - BPR) concerns the making available on the market and use of all products which, due to the specificity of the substances they contain (active ingredients), are used to protect human beings, animals, materials or commonly used items from the action of harmful organisms, such as parasites or bacteria.
BPR came into force on 1 September 2013 and from that date the previous regulatory framework on biocidal products (Dir 98/8/EC) is to be considered repealed.
With the adoption of the BPR, a harmonised overarching biocidal management system was established throughout the European Union. In fact, the BPR not only establishes detailed provisions on how to conduct scientific assessment of the risks associated with active substances and biocidal products, but provides all companies with specific information on how to obtain the necessary authorisations from the respective authorities to make a biocidal product available on the market in any country belonging to the European Union. The BPR also stimulates the reduction of animal testing by introducing data sharing obligations and encouraging the use of alternative testing methods.